These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

465 related items for PubMed ID: 9377834

  • 1. [Prevention of bacterial and fungal infections in neutropenic patients with malignant hematologic diseases].
    Candoni A, Russo D, Salmaso F.
    Clin Ter; 1997; 148(1-2):23-8. PubMed ID: 9377834
    [Abstract] [Full Text] [Related]

  • 2. Antimicrobial prophylaxis for infection in neutropenic patients.
    Bodey GP.
    Curr Clin Top Infect Dis; 1988; 9():1-43. PubMed ID: 3077285
    [No Abstract] [Full Text] [Related]

  • 3. Emerging role of quinolones in the prevention of gram-negative bacteremia in neutropenic cancer patients and in the treatment of enteric infections.
    Bow EJ, Louie TJ.
    Clin Invest Med; 1989 Feb; 12(1):61-8. PubMed ID: 2646056
    [Abstract] [Full Text] [Related]

  • 4. Itraconazole prevents invasive fungal infections in neutropenic patients treated for hematologic malignancies: evidence from a meta-analysis of 3,597 patients.
    Glasmacher A, Prentice A, Gorschlüter M, Engelhart S, Hahn C, Djulbegovic B, Schmidt-Wolf IG.
    J Clin Oncol; 2003 Dec 15; 21(24):4615-26. PubMed ID: 14673051
    [Abstract] [Full Text] [Related]

  • 5. An open-label randomized trial comparing itraconazole oral solution with fluconazole oral solution for primary prophylaxis of fungal infections in patients with haematological malignancy and profound neutropenia.
    Glasmacher A, Cornely O, Ullmann AJ, Wedding U, Bodenstein H, Wandt H, Boewer C, Pasold R, Wolf HH, Hänel M, Dölken G, Junghanss C, Andreesen R, Bertz H, Itraconazole Research Group of Germany.
    J Antimicrob Chemother; 2006 Feb 15; 57(2):317-25. PubMed ID: 16339606
    [Abstract] [Full Text] [Related]

  • 6. [Antimicrobial prophylaxis and therapy in neutropenia].
    Link H.
    Mycoses; 2003 Feb 15; 46 Suppl 2():21-32. PubMed ID: 15055140
    [Abstract] [Full Text] [Related]

  • 7. Fluconazole versus itraconazole for antifungal prophylaxis in neutropenic patients with haematological malignancies: a meta-analysis of randomised-controlled trials.
    Vardakas KZ, Michalopoulos A, Falagas ME.
    Br J Haematol; 2005 Oct 15; 131(1):22-8. PubMed ID: 16173959
    [Abstract] [Full Text] [Related]

  • 8. Evidence-based review of antifungal prophylaxis in neutropenic patients with haematological malignancies.
    Glasmacher A, Prentice AG.
    J Antimicrob Chemother; 2005 Sep 15; 56 Suppl 1():i23-i32. PubMed ID: 16120631
    [Abstract] [Full Text] [Related]

  • 9. [Prophylaxis of infection in neutropenic patients. Guidelines of the Working Party on Infections in Hematology and Oncology].
    Kern WV, Beyer J, Böhme A, Buchheidt D, Cornely O, Einsele H, Kisro J, Krüger W, Maschmeyer G, Ruhnke M, Schmidt CA, Schwartz S, Szelenyi H, Arbeitsgemeinschaft Infektionen in der Hämatologie und Onkologie der DGHO.
    Dtsch Med Wochenschr; 2000 Dec 22; 125(51-52):1582-8. PubMed ID: 11199452
    [No Abstract] [Full Text] [Related]

  • 10. The changing face of febrile neutropenia-from monotherapy to moulds to mucositis. Why empirical therapy?
    Klastersky J.
    J Antimicrob Chemother; 2009 May 22; 63 Suppl 1():i14-5. PubMed ID: 19372173
    [Abstract] [Full Text] [Related]

  • 11. Infectious complications after autologous peripheral blood progenitor cell transplantation followed by G-CSF.
    Offidani M, Corvatta L, Olivieri A, Rupoli S, Frayfer J, Mele A, Manso E, Montanari M, Centurioni R, Leoni P.
    Bone Marrow Transplant; 1999 Nov 22; 24(10):1079-87. PubMed ID: 10578158
    [Abstract] [Full Text] [Related]

  • 12. [Prevention of mycotic infections in oncology patients with regard to the toxicity of antimycotic agents].
    Doubek M, Mayer J, Horký D, Doubek J, Rácil Z, Vorlícek J.
    Vnitr Lek; 2002 Mar 22; 48(3):248-54. PubMed ID: 11968587
    [Abstract] [Full Text] [Related]

  • 13. [Azole antifungal agents in the prevention of fungal infections in neutropenic patients and bone marrow graft recipients].
    Lortholary O, Dupont B.
    Ann Med Interne (Paris); 1997 Mar 22; 148(3):258-67. PubMed ID: 9255336
    [Abstract] [Full Text] [Related]

  • 14. Prophylaxis and treatment of bacterial infections: do we need new strategies?
    Micozzi A, Bucaneve G.
    Rev Clin Exp Hematol; 2005 Dec 22; 9(2):E4. PubMed ID: 16864118
    [Abstract] [Full Text] [Related]

  • 15. [Evaluation of antibiotic prophylaxis in neutropenic patients with hematologic malignancies].
    Delarive P, Baumgartner JD, Glauser MP, Cometta A.
    Schweiz Med Wochenschr; 2000 Dec 02; 130(48):1837-44. PubMed ID: 11132527
    [Abstract] [Full Text] [Related]

  • 16. Low morbidity and mortality from infection in neutropenic patients, a possible result of multiple measures of infection prevention.
    Grob JP, Francioli P, Pécoud A, Glauser MP.
    Schweiz Med Wochenschr Suppl; 1983 Dec 02; 14():70-5. PubMed ID: 6581532
    [Abstract] [Full Text] [Related]

  • 17. Antifungal prophylaxis for severely neutropenic chemotherapy recipients: a meta analysis of randomized-controlled clinical trials.
    Bow EJ, Laverdière M, Lussier N, Rotstein C, Cheang MS, Ioannou S.
    Cancer; 2002 Jun 15; 94(12):3230-46. PubMed ID: 12115356
    [Abstract] [Full Text] [Related]

  • 18. Antifungal prophylaxis with itraconazole oral solution in neutropenic patients.
    Kibbler CC.
    Mycoses; 1999 Jun 15; 42 Suppl 2():121-4. PubMed ID: 10865918
    [Abstract] [Full Text] [Related]

  • 19. [Application of the concepts of evidence-based medicine to the evidence on the treatment of febrile neutropenia].
    Jarque I, Sanz MA.
    Enferm Infecc Microbiol Clin; 1999 Jun 15; 17 Suppl 2():95-102. PubMed ID: 10605194
    [Abstract] [Full Text] [Related]

  • 20. Antimicrobial chemoprophylaxis in immunocompromised patients.
    Frøland SS.
    Scand J Infect Dis Suppl; 1990 Jun 15; 70():130-40. PubMed ID: 2287895
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.